| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/03/2013 | US20130004555 Cosmetic Compositions Comprising Esters Based on 2-Propylheptanol |
| 01/03/2013 | US20130004554 Microalgae-Derived Compositions for Improving the Health and Appearance of Skin |
| 01/03/2013 | US20130004552 Water dispersible nonwoven fabric material |
| 01/03/2013 | US20130004551 Biotinylated hexadecasaccharides, preparation and use thereof |
| 01/03/2013 | US20130004550 Sustained-release solid preparation for oral use |
| 01/03/2013 | US20130004549 Cell support and bone regeneration material |
| 01/03/2013 | US20130004548 Medical devices having pharmacological active agent releasing material |
| 01/03/2013 | US20130004547 Oral vaccines produced and administered using edible micro-organisms including lactic acid bacterial strains |
| 01/03/2013 | US20130004546 Hydrogel of microspheres |
| 01/03/2013 | US20130004545 Slow release pharmaceutical compositions of iloperidone |
| 01/03/2013 | US20130004544 Synthetic Antibacterial Clay Compositions and Method of Using Same |
| 01/03/2013 | US20130004543 Fibronectin: growth factor chimeras |
| 01/03/2013 | US20130004542 Composition |
| 01/03/2013 | US20130004526 Utilization of Dialkylfumarates |
| 01/03/2013 | US20130004435 Azeotrope-like compositions comprising 1-chloro-3,3,3-trifluoropropene |
| 01/03/2013 | US20130004425 Biomineral and Metal Binding Liposomes, Their Synthesis, and Methods of Use Thereof |
| 01/03/2013 | US20130004415 Joint-Homing Peptides and Uses Thereof |
| 01/03/2013 | CA2877102A1 Topical formulations including lipid microcapsule delivery vehicles and their uses |
| 01/03/2013 | CA2840765A1 Multilayered dosage form |
| 01/03/2013 | CA2840734A1 Macrogol 15 hydroxystearate formulations |
| 01/03/2013 | CA2840617A1 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 01/03/2013 | CA2840571A1 High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis |
| 01/03/2013 | CA2840491A1 Topical ophthalmological pharmaceutical composition containing sorafenib |
| 01/03/2013 | CA2840329A1 Topical ophthalmological pharmaceutical composition containing regorafenib |
| 01/03/2013 | CA2840155A1 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | CA2840152A1 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | CA2839853A1 Flat self-curling permeable sheet membrane |
| 01/03/2013 | CA2839624A1 Applicator system for applying a viscous liquid to the human skin |
| 01/03/2013 | CA2839387A1 An aqueous composition comprising a biological antigen and an acrylic acid polymer |
| 01/03/2013 | CA2839179A1 A new stable anesthetic composition for reducing skin reactions |
| 01/03/2013 | CA2834681A1 Stabilized topical formulations containing core-shell microcapsules |
| 01/03/2013 | CA2827130A1 Toroidal pharmaceutical formulations |
| 01/02/2013 | EP2540318A1 Sustained-release solid preparation for oral use |
| 01/02/2013 | EP2540317A1 Sustained-release solid preparation for oral use |
| 01/02/2013 | EP2540311A1 Composite body for antigen or drug delivery |
| 01/02/2013 | EP2540298A1 Coated solid preparation |
| 01/02/2013 | EP2540294A1 Sustained-release solid preparation for oral use |
| 01/02/2013 | EP2540289A1 Adhesive patch containing bisoprolol |
| 01/02/2013 | EP2540288A1 Adhesive skin patch |
| 01/02/2013 | EP2540287A1 Continuous flow production of gelatin nanoparticles |
| 01/02/2013 | EP2540286A1 Hard capsule and method for producing same |
| 01/02/2013 | EP2540285A1 Capsule of complex danshen drop pill |
| 01/02/2013 | EP2540284A2 Compositions and methods for stabilized polysaccaride formulations |
| 01/02/2013 | EP2540283A1 Improved botulinum toxin compositions |
| 01/02/2013 | EP2540282A2 Surface-modified tantalum oxide nanoparticles, preparation method thereof, and contrast medium for x-ray computed tomography and highly dielectric thin film using same |
| 01/02/2013 | EP2540281A1 Solid self-microemulsifying systems |
| 01/02/2013 | EP2539312A1 Nutritional composition |
| 01/02/2013 | EP2538992A2 Slow release liquid drug delivery device |
| 01/02/2013 | EP2538975A2 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 01/02/2013 | EP2538974A1 Protein formulations |
| 01/02/2013 | EP2538966A1 Long-acting insulin analogue preparations in soluble and crystalline forms |
| 01/02/2013 | EP2538955A2 Pharmaceutical or neutraceutical formulation |
| 01/02/2013 | EP2538950A1 Zeolite-containing preparations containing clinoptilolite and uses thereof |
| 01/02/2013 | EP2538930A1 Formulations for oral delivery of adsorbents in the gut |
| 01/02/2013 | EP2538929A2 Sustained delivery of therapeutic agents to an eye compartment |
| 01/02/2013 | EP2538928A2 Abuse-resistant formulations |
| 01/02/2013 | EP2538927A1 Rapid-release encapsulation composition |
| 01/02/2013 | EP2538926A2 Veterinary compositions |
| 01/02/2013 | EP2538925A2 Apixaban formulations |
| 01/02/2013 | EP2538924A2 Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation |
| 01/02/2013 | EP2538923A2 Taste-masked powder for suspension compositions of methylprednisolone |
| 01/02/2013 | EP2538922A1 Formulation of compositions for the treatment of inflammatory conditions |
| 01/02/2013 | EP2538921A2 Method and apparatus for preparing novel liposome |
| 01/02/2013 | EP2538920A1 Emollient foams for treatment of dermatoses |
| 01/02/2013 | EP2538919A2 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| 01/02/2013 | EP2538918A1 Citicoline for the treatment of glaucoma and ocular hypertension |
| 01/02/2013 | EP2538779A1 Diversion-and/or abuse-resistant compositions and methods for making the same |
| 01/02/2013 | CN202637539U Novel rheumatism analgesic ointment |
| 01/02/2013 | CN202637538U Rheumatic pain relieving paste |
| 01/02/2013 | CN202637537U Rheumatism sticking plaster capable of being pasted on wounded skin surface |
| 01/02/2013 | CN202637536U Air permeable plaster for rheumatism |
| 01/02/2013 | CN202637535U Plaster patch |
| 01/02/2013 | CN202637534U Ointment plaster |
| 01/02/2013 | CN202637533U Compound bismuth potassium citrate capsule |
| 01/02/2013 | CN202637532U Gastroscope anesthetic packing sugar |
| 01/02/2013 | CN202637503U Hollow capsule |
| 01/02/2013 | CN202637269U Medicinal magnetic acupuncture point plaster |
| 01/02/2013 | CN1988884B Controlled release matrix pharmaceutical dosage formulation |
| 01/02/2013 | CN1777411B Transmucosal drug delivery system |
| 01/02/2013 | CN1602835B Aerosol cosmetic composition |
| 01/02/2013 | CN102858682A Method for preparing nano-particles |
| 01/02/2013 | CN102858640A Process for providing a filled canister for an inhaler |
| 01/02/2013 | CN102858449A Capsule comprising active ingredient |
| 01/02/2013 | CN102858417A Method for producing crystalline active ingredient particles |
| 01/02/2013 | CN102858374A Thermogelling anaesthetic compositions |
| 01/02/2013 | CN102858373A Easily dosable solid preparation |
| 01/02/2013 | CN102858372A Skin irritation suppressant and transdermal preparation |
| 01/02/2013 | CN102858367A Composite body for antigen or drug delivery |
| 01/02/2013 | CN102858366A Solution Preparation Containing Stabilized Antibody |
| 01/02/2013 | CN102858351A Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy |
| 01/02/2013 | CN102858350A Nail discoloration and fungus treatment |
| 01/02/2013 | CN102858349A Pharmaceutical Composition For The Treatment Of Alzheimer's Disease, Method For Producing Same And Use Thereof |
| 01/02/2013 | CN102858343A Methods and compositions for treating or preventing symptoms of hormonal variations |
| 01/02/2013 | CN102858337A Diindolylmethane-based drug for the treatment of hyperplastic and inflammatory diseases |
| 01/02/2013 | CN102858332A Ketoprofen-containing aqueous adhesive skin patch |
| 01/02/2013 | CN102858331A Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 01/02/2013 | CN102858327A Oral dosage forms |
| 01/02/2013 | CN102858326A Process for preparing carrier particles for dry powders for inhalation |
| 01/02/2013 | CN102858325A Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent |
| 01/02/2013 | CN102858324A Double-layer pharmaceutical formulations containing opioid agonists and antagonists |